Spruce Point Capital Reiterates Strong Sell On Xylem; Sees 30%–45% Downside Risk ($58.00–$74.00 Per Share) And Expect Xylem To Underperform The S&P 500
Portfolio Pulse from Happy Mohamed
Spruce Point Capital has reiterated its strong sell recommendation on Xylem, predicting a 30%-45% downside risk ($58.00-$74.00 per share) and expecting Xylem to underperform the S&P 500.
September 05, 2023 | 3:09 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Spruce Point Capital expects Xylem's stock to underperform the S&P 500 with a 30%-45% downside risk.
Spruce Point Capital, a known investment research firm, has reiterated a strong sell recommendation on Xylem. This negative outlook, coupled with the predicted 30%-45% downside risk, is likely to impact investor sentiment and potentially drive the stock price down in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100